LaserLeap Technologies was founded to address the need for a painless method of delivering drugs through the skin and to promote faster, more effective treatments. Two decades of research with lasers and ultrasound resulted in technology that combines affordable lasers with innovative materials capable of making our skin permeable to drugs and cosmetics in a safe, painless, and effective manner. LaserLeap opened for business in 2011, in Coimbra, Portugal, focused in the development of a method for permeating skin and allow the delivery of cosmetics and drugs, along with anesthetics, skin cancer drugs, vaccines and biotechnology drugs.
Looking for a particular LaserLeap Technologies employee's phone or email?
The LaserLeap Technologies annual revenue was $601000 in 2026.
Carlos Serpa is the CEO of LaserLeap Technologies.
2 people are employed at LaserLeap Technologies.
LaserLeap Technologies is based in Coimbra, Coimbra.
The NAICS codes for LaserLeap Technologies are [54, 54171, 541, 5417, 541713].
The SIC codes for LaserLeap Technologies are [87, 873].